It is conceivable that a higher intracellular concentration of MQ in the context of diminished GSH levels will allow more extensive modification of key mutant p53 cysteines or other protein thiols, and thus more efficient mutant p53 activation and subsequent tumor cell killing. The gene discussed is TP53; the disease is neoplasm.